drugset / Trial / NCT00855738
A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice
NaSingle-groupOpen-labelTreatment
Summary
Assessment of the efficacy under daily clinical conditions of the new antiepileptic drugs (AEDs) gabapentin, lamotrigine, levetiracetam, oxcarbazepine, pregabalin, tiagabine and topiramate, used as first-choice combination therapy (bitherapy) in patients with focal epilepsy.
Timeline
- Start
- 2007-05
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gabapentin | Small molecule | 3600 mg | — |
| Subject | Lamotrigine | Small molecule | 400 mg | — |
| Subject | Levetiracetam | Other / unclassified | 3000 mg | — |
| Subject | Oxcarbazepine | Small molecule | 2400 mg | — |
| Subject | Pregabalin | Small molecule | 600 mg | — |
| Subject | Tiagabine | Small molecule | 30 mg | — |
| Subject | Topiramate | Small molecule | 400 mg | — |
| Subject | Zonisamide | Other / unclassified | 500 mg | — |